Rearranged immunoglobulin heavy chain (IgH) genes provide be used for diagnosis, ie clonality analysis, and for the detec- 
rearrangements from these cells will compete for PCR primers and nucleotides, thereby lowering amplification efficiency of the tumor-specific IgH rearrangement. If the rearranged IgH Introduction genes from the normal B cells provide better PCR priming sites than the rearranged IgH gene from the tumor, the former may Most patients suffering from intermediate-and high-grade become the major product of the PCR, leading to false positive malignant B cell non-Hodgkin's lymphoma (NHL) achieve a results, in particular when excess amplification cycles are complete clinical remission (CCR) following conventional used. Clonality assessment is therefore necessary to dischemotherapy. However, only 50% of these patients appear tinguish between a monoclonal IgH-PCR product that is precured, and most of the remaining patients relapse within 2 sumably derived from tumor cells, and an oligoclonal or polyyears. 1 It could be of considerable clinical interest to be able clonal product derived from normal B cells. to determine which patients have residual disease and may
In this paper we describe a general strategy for the generbenefit from additional or more intensified therapy. Currently ation and evaluation of lymphoma-specific molecular markers the polymerase chain reaction (PCR) is the most sensitive techbased on the rearranged IgH gene. Using an extensive PCR nique to detect low numbers of tumor cells. [2] [3] [4] Since the primer set, monoclonal IgH rearrangements were isolated majority of intermediate-and high-grade malignant NHL do from 11/13 lymphoma biopsies. Using PCR primers defined in not contain known chromosomal translocations, 5 alternative the CDR3 domain, lymphoma-specific rearranged IgH genes PCR targets must be defined for these malignancies.
could be routinely detected following 10 000-fold dilution in Rearranged immunoglobulin heavy chain (IgH) genes problood leukocyte DNA. Lymphoma-specific rearranged IgH vide unique molecular markers for clonally related B lymphogenes were subsequently also detected in peripheral blood cytes. The rearranged IgH gene consists of a VH-DH-JH comand bone marrow samples of three NHL patients with different bination assembled from approximately 50 VH genes, clinical courses. approximately 20 DH genes and six JH genes, by a recombinatorial process. In addition to the combinatorial diversity, variability is increased by deletion and/or non-template Materials and methods addition of nucleotides as the junctional regions. Thus, for each particular B cell clone a unique molecular signature Cloning and characterization of rearranged IgH genes (designated complementarity determining region 3 (CDR3)) is from lymphoma biopsies created. 6 The rearranged IgH gene of malignant B cells may DNA isolated from lymphoma biopsies ( that by Southern blotting were found to contain a monoclonal b   123  retroperitoneum  DLBCL  II  M   53  F  2  207  supraclavicular  DLBCL  III  −   c   −   c   72  F  2  210  neck  FCLD  IV  G   46  M  2  212  stomach  MZBCLN  IV  M,D   56  M  2  219  mediastinum  FCLD  II  −   c   −   c   19  M  2  221  mediastinum  DLBCL  II  ND  ND  28  F  2  222  axilla  MCL  IV  M,D   49  M  1  223  tongue base  DLBCL  III  ND  ND  58  M  1  262  stomach  MZBCLE  II  ND  ND  54  M  2  311  groin  DLBCL  III  M   53  F  2 B cell population were subjected to PCR using the extensive and resolution. Prominent bands of correct size were cut from the gel, eluted, and reamplified by PCR. primer set ( Figure 1 , Table 2 ). PCR was performed on Omnigene (Hybaid, Teddington, UK) and Robocycler gradient 40 Clonality of the PCR products was assessed by direct sequencing or by sequencing of cloned products. For direct (Stratagene, La Jolla, CA, USA) thermocyclers, in 25 l consisting of 50 mM KCl, 10 mM Tris.HCl (pH 9), 0.1% Triton Xsequencing, PCR products were gel-purified using a commercially available kit (Jetsorb; Genomed, Research Triangle Park, 100, 0.2 mM dATP, dCTP, dGTP, and dTTP, 1.5 mM MgCl 2 , 0.2 U Taq DNA polymerase (Promega, Leiden, The NC, USA), and sequenced using one of the PCR primers. For cloning, 1 l of PCR product or gel-purified PCR product was Netherlands), and 100 ng lymphoma DNA. PCR conditions were as follows: 5 min 94°C, followed by 25-30 cycles of ligated into the TA cloning vector pCR-II (Invitrogen, Leek, The Netherlands), and transfected into E. coli strain INV␣FЈ. 30-60 s 94°C, 1 min T a , 1 min 72°C, and subsequently 10 min 72°C. Annealing temperature T a depends on primer Clones were either sequenced manually by T7 polymerase in the presence of radiolabeled dATP, or automatically sequence and ranged between 56 and 60°C. PCR products were size-separated on 1.5-2% agarose gels stained with ethisequenced on an ABI 377 sequencer using fluorescent dye terminators as recommended by the manufacturer (Perkin dium bromide, blotted, and probed with a mixture of cloned VH sequences. 36 PCR products of the expected size that Elmer, Nieuwerkerk a/d IJssel, The Netherlands). At least two independent PCR products from a single primer set were anahybridized to the VH probe were subjected to clonality analysis as described below. If only a low amount or heterogeneous lyzed. To identify the most homologous VH germline genes, DNA sequences of the rearranged IgH genes were compared PCR product was obtained, the analysis was repeated using radioactively labeled dATP, and PCR products were analyzed to Genbank/EMBL sequences by Blast search, 37 or to germline IgH sequences as deposited in the V-BASE directory on a denaturing 6% polyacrylamide gel to increase sensitivity
Figure 1
Schematic organization of the rearranged VH gene. The position of the PCR primers is indicated. [38] [39] [40] germline genes were subsequently aligned with the rearranged IgH genes to determine DNA was isolated from 13 intermediate-/high-grade maligthe boundaries of the CDR3 domain, using DNAMAN nant lymphomas that contained one or two rearranged IgH software (Lynnon Biosoft, Quebec, Canada).
genes as detected by Southern blotting and hybridization with a JH probe ( Table 1) . Amplification of tumor-specific rearranged IgH genes was attempted by PCR. To minimize the risk of false negative or false positive results an extensive PCR primer set ( Figure 1 , Table 2 ) and stringent selection criteria
Minimal disease detection were applied. The cloned IgH rearrangements are considered to be of tumor origin if the PCR product was predominantly monoclonal, and the same rearrangement was amplified with DNA isolated from peripheral blood (PB) and bone marrow (BM) samples as described previously 34 was subjected to PCR two independent VH primers. Clonality was assessed by direct sequencing of PCR products. Alternatively, PCR products of using lymphoma-specific primers defined in the CDR3 domain. PCR conditions were as described above, except that at least two amplifications were cloned and individual clones were characterized by sequencing. Using the latter approach, 500 ng target DNA was used, reaction volume was 50 l, and 30 cycles were performed. PCR products were size-separated rearranged IgH genes that differed from the lymphoma-specific rearrangement were occasionally found, but these generon 1.5-2% agarose gels, blotted, and hybridized to radiolabeled probes using standard techniques. 41 Lymphoma-specific ally represented a minority of the clones and were not found using another primer set. CDR3 probes were generated as described 42 with some modifications. Cloned IgH rearrangements were amplified with Eleven lymphomas (85%) yielded monoclonal PCR products with two or more independent VH primers ( Table 3) . FR3C and JHint primers ( Table 2 ). The PCR product was digested with HaeIII to remove conserved JH sequences, and Sequencing revealed that from each lymphoma the same rearranged IgH gene was amplified by the independent VH radiolabeled using Klenow DNA polymerase and random hexamer primers. In order to exclude false negativity due to DNA primers, strongly suggesting that these IgH rearrangements are indeed derived from tumor cells. The rearranged IgH genes degradation or the presence of PCR inhibitors, the IL-3 gene was amplified from the samples as described. 34 showed 83-100% homology with their respective germline VH and JH genes (Table 3) . CDR3 lengths ranged from 15 to PCR in which proofreading DNA polymerase was used, five clones were sequenced completely, and from nine clones the 51 nucleotides (Tables 3 and 4 ). All rearranged IgH genes appear potentially functional, since their junctional domains JH, CDR3, and part of the VH domain were sequenced. In 3563 nucleotides, 11 deviations from the most abundant allow maintenance of the correct open reading frame throughout the VH and JH regions.
clone were found, of which five were present in more than one clone from independent PCRs. The six unique mutations Rearranged IgH genes from lymphomas have been shown to exhibit intraclonal sequence variation, [29] [30] [31] [32] [33] apparently due may originate from Taq polymerase errors, since they are more frequent in clones amplified with Taq polymerase (five to ongoing hypermutation in the tumor cells. To minimize the possibility that tumor subclones are missed because they are mutations/2207 nucleotides) than in clones amplified with proofreading polymerase (1/1356). Taking only the five shared not recognized by lymphoma-specific primers, intraclonal sequence heterogeneity has to be characterized prior to minimutations into account, three sequence variants were observed (Figure 2a) . Interestingly, from a relapse biopsy taken mal disease investigation. Therefore, of the three lymphomas selected for minimal disease studies, multiple clones from two 19 months following diagnosis a fourth sequence variant was isolated (311-D, Figure 2a) . The variant was found in all four or more independent PCRs were sequenced. Sequencing of six clones from tumor 222 (901 bases in total since not all clones from the relapse that were sequenced, indicating selective outgrowth of an initially minor clone. Sequence variation clones were sequenced completely) and nine clones from tumor 325 (2082 bases in total) revealed no sequence heteroin the CDR3 domain is of particular importance, since this region is the prime target for minimal disease detection. The geneity apart from a single point mutation in one clone from each tumor. These two point mutations were probably caused clones described above contained a single nucleotide variation at the 5Ј end of the CDR3 domain. The CDR3 domains by Taq polymerase errors. 2 From three independent PCRs of tumor 311, including a of 10 additional clones of lymphoma 311 and 12 clones from Part of the germline VH and JH genes is shown. Nucleotides that differ from germline sequences are indicated in lower case. DNA sequences complementary to lymphoma-specific PCR primers are underlined.
Figure 2
Intraclonal sequence heterogeneity in two lymphoma IgH rearrangements. The DNA sequence of the rearranged IgH genes is compared to germline VH and JH sequences (top lines). Identities are indicated by dashes, except in primers where they are represented by dots. Primer sequences and CDR domains are indicated. Mutations are shown as lower case letters; intraclonal sequence variations are printed in bold, and primer-germline sequence mismatches are in italics. (a) Lymphoma 311 was found to contain three sequence variants. Variants 311-A, 311-B, and 331-C were represented by four, six and four clones, respectively. Variant 311-D, that was not observed in the primary lymphoma biopsy at diagnosis, was isolated from a relapse biopsy using primer 1C2. (b) Sequence variants 221-A and 221-B from lymphoma 221 were represented by five and three clones, respectively. the relapse were investigated by denaturing gradient gel Intraclonal sequence heterogeneity was also discovered in a fourth lymphoma (221) not selected for minimal disease electrophoresis. No further differences were detected. At the variant position in the CDR3 domain of the rearranged IgH investigation. Sequencing of eight clones from two independent PCRs revealed the presence of two sequence variants genes isolated from the lymphoma, a G was found in 17 clones, and seven clones contained an A. In the relapse, all of the rearranged IgH gene that showed 16% difference in their DNA sequence (Figure 2b ). Denaturing gradient gel 16 clones examined contained a G in this position. electrophoresis and heteroduplex analysis of the PCR product lymphomas for which they were designed, but not from unrelated lymphomas that used the same VH family, indicating and the two clones indicated that no additional clones were present (not shown).
that the primers are indeed specific (Figure 3 ). Sensitivity was determined using serial dilutions of lymphoma DNA in normal blood DNA as PCR target. Following Southern hybridization using the lymphoma-specific probe, specific PCR products were detected in the 10 −4 dilution (Figure 3 ).
Minimal disease detection
Peripheral blood and bone marrow samples from three patients with different clinical courses were investigated for Following characterization of the intraclonal sequence variation, lymphoma-specific PCR primers were defined in the the presence of lymphoma-specific IgH rearrangements. All experiments were performed at least in duplicate. Control CDR3 domain not subjected to intraclonal variation ( Table 4) . The primers amplified products of the expected size from the experiments include amplification of the IL-3 gene to confirm
Figure 3
Detection of lymphoma-specific rearranged IgH genes in peripheral blood or bone marrow samples. PCR products obtained using a lymphoma-specific CDR3 primer combined with a primer in the VH domain were size-separated on 1.8% agarose gel, blotted, and visualized by hybridization to radiolabeled lymphoma-specific probe. For lymphoma 311, the probe was generated from the 311-A variant. Time following diagnosis is indicated in months. Bone marrow samples are indicated with an asterisk, other follow-up samples were taken from peripheral blood. Detection sensitivity was determined by serial dilution of lymphoma DNA in DNA isolated from normal donor blood. Negative controls included unrelated tumors that used the same VH family, normal peripheral blood DNA (NPB), DNA isolated from ZR75.1 human breast epithelial cells, 67 and a no-DNA control. The bone marrow was harvested from patient 311 2 months after diagnosis and re-infused 3 months later.
sample quality. Patient 222, who suffered from a mantle cell nantly monoclonal due to the abundancy of tumor cells in the sample. However, when the PCR primers hybridize ineflymphoma, never achieved CCR and died 4 years after diagnosis. PCR results for this patient were strongly positive at all ficiently to the rearranged IgH gene from tumor cells due to, for example, somatic hypermutation, the PCR product may be time-points investigated ( Figure 3 ). Patient 311, who carried a diffuse mixed small and large cell lymphoma, entered partial dominated by sequences derived from normal B cells present in the biopsy. It is therefore essential to be able to discriminate remission following chemotherapy, and transient CCR upon high-dose chemotherapy followed by autologous bone marbetween PCR products derived from normal B cells, that are oligo-or polyclonal, and PCR products derived from maligrow transplantation. However, the patient suffered from nodal relapses 9, 19 and 25 months after diagnosis. Following nant cells, that are monoclonal. These considerations have led us to impose some practical restrictions: (1) only tumors in chemotherapy and local radiotherapy, the patient achieved CCR 37 months after diagnosis, and is in continuing remission which a monoclonal B cell population could be detected by Southern blotting were entered in this study; (2) a limited for almost 3 years now. The lymphoma-specific IgH rearrangement was detected in the bone marrow transplant, number (25-30) of PCR cycles was performed to minimize the accumulation of PCR product from nonmalignant B cells; and in PB samples up to 22 months after diagnosis ( Figure 3 , and not shown), and in a biopsy of the second relapse (not shown).
(3) identical products should be recovered from PCRs using different non-overlapping VH primers. Cloning of PCR proThe sample taken at 50 months, however, was PCR negative. Peripheral blood samples taken 64 and 67 months following ducts followed by sequencing of individual clones appears to be the most practical method for clonality assessment of diagnosis were also negative (not shown). Patient 325, who suffered from a diffuse mixed small and large cell lymphoma, rearranged IgH genes amplified from lymphomas. Alternatively, clonality has been determined by direct sequencing of entered CCR following induction chemotherapy. Thirty months after diagnosis a nodal relapse was detected and PCR product. 24 However, the latter method is more easily disturbed by the presence of rearranged IgH genes derived from treated by local radiotherapy, upon which the patient entered CCR again. Peripheral blood samples from this patient were normal B cells. Moreover, intraclonal sequence heterogeneity (see below) is easier to detect by sequencing of clones than either negative or weakly positive during the first 31 months following diagnosis (not shown), indicating that the number by direct sequencing of PCR product. From 11 of 13 intermediate-and high-grade malignant of tumor cells was at the detection threshold. Samples taken at 67 and 74 months were PCR negative. During the entire NHL, rearranged IgH genes were amplified by PCR. The two lymphomas from which no monoclonal rearranged IgH genes study period, no tumor cells were detected by morphological and immunological examination of BM and PB samples from were isolated by PCR (207 and 219) showed no immunoglobulin expression by immunochemistry. From each of the other patients 311 (n = 12) and 325 (n = 6).
lymphomas the same rearranged gene was cloned with two or more independent VH primers, strongly suggesting that the rearranged gene was derived from tumor cells. In addition to Discussion allowing verification of the cloned sequence, the use of an extensive PCR primer set improves the efficiency of IgH Clonality assessment and efficiency of IgH cloning from intermediate-and high-grade malignant NHL rearrangement amplification from lymphomas. [43] [44] [45] [46] The limited detection efficiency reported with single primer sets [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] has been suggested to be due to somatic hypermutation of Amplification of rearranged IgH genes from lymphoma biopsies is expected to yield PCR products that are predomithe rearranged IgH gene. Our data support this hypothesis.
Comparison of FR3 consensus primers used in two recent
Intermediate-/high-grade NHL have been reported to exhibit intraclonal sequence heterogeneity of the rearranged IgH studies 23, 45 with the lymphoma IgH sequences described in this paper showed that eight out of 11 rearranged IgH genes gene, albeit at lower frequency than in follicular NHL. [31] [32] [33] To minimize the likelihood that subclones are missed because differed from both primer sequences. In three lymphomas, mutations were located close to the 3Ј end of the primers. lymphoma-specific primers or probes are chosen in variable regions, it is essential to determine the extent of intraclonal Another example is provided by tumor 325, that repeatedly yielded a PCR product with the VH4-FR1A (4A) primer but sequence variation prior to minimal disease investigation. In two of the three lymphomas selected for minimal disease only occasionally with the VH4-FR1B (4B) primer. Analysis of the sequence of the 4A product revealed the presence of two study, no sequence differences were found within six (lymphoma 222) and nine (lymphoma 325) clones, indicating mutations in the 4B region, one being located at the fourth position from the 3Ј end of the 4B primer, that apparently that in these lymphomas intraclonal sequence heterogeneity is low or absent. In the third lymphoma (311) sequencing of caused the poor amplification with this primer.
In eight lymphomas two rearranged IgH genes were 14 clones revealed three sequence variants, and a fourth variant was detected in a relapse biopsy. One variable site was detected by Southern blotting, whereas a single rearranged IgH gene was amplified by PCR using two or more non-overlocated in the CDR3 domain. However, the intraclonal sequence heterogeneity did not prevent the definition of a lapping VH primers. It is unlikely that this phenomenon is due to sampling error, since a similar observation was made in lymphoma-specific primer, or minimal disease detection. In contrast to results reported for follicular NHL, two out of two other studies. 32, 55 The most likely explanation appears to be aberrant rearrangement of the second allele, eg due to four intermediate-/high-grade NHL lack intraclonal sequence heterogeneity of their rearranged IgH genes. However, lymincomplete rearrangement or chromosomal translocation. Translocation t(14;18) is unlikely to be involved in the lymphoma 222 is a mantle cell lymphoma (CD5 + /CD23 − ), and these lymphomas have been shown to lack somatic phomas described here, since it was detected by PCR only in lymphoma 123.
mutations, 57 and thus intraclonal variety. The lack of intraclonal sequence variation in lymphoma 325 is more surprising, since the rearranged IgH gene from this tumor shows 6% VH and JH family use, somatic hypermutation, and deviation from germline VH. A similar lack of intraclonal intraclonal sequence heterogeneity sequence heterogeneity (in the presence of somatic mutations) has been reported for 12 out of 15 diffuse large cell Most of the IgH rearrangements were derived from members of the VH3 and VH4 families, that are also the most frequently lymphomas. 33 used VH families in EBV-transformed peripheral blood B cells 59 and follicular lymphomas. 60 Two lymphomas were found to use the V4-34 gene, in agreement with literature data Minimal disease detection that report frequent use of V4-34 in intermediate-and highgrade malignant lymphoma, 61 diffuse large cell lymphoma, 33 Several strategies have been developed to detect tumor-specific rearranged IgH genes in remission blood and bone marand the normal adult peripheral blood B cell repertoire. 62 Of the JH genes, the JH4b allele was most frequently used (6/11 row samples from patients with B cell malignancies. Specificity was obtained either by hybridization of PCR product lymphomas), in accordance with literature data. 40 The rearranged genes from all lymphomas showed deviations from with an IgH-specific probe, 7,9,15-17,23,24,42,74 by PCR with IgHspecific primers, 10,13,14,74,75 a combination of specific CDR2 their closest germline counterparts currently present in sequence databases. Homology to published VH germline primer with CDR3 probe, 22 or by sequential use of consensus primers, specific primers, and a specific probe. 19 The method genes ranged from 83 to almost 100%. Since apparently all heavy chain variable regions have been cloned and presented here employs IgH-specific PCR primers, because primers that amplify only the sequence of interest are sequenced, it is likely that the observed deviations are due to somatic mutations; however, a role of germline polymorexpected to be more sensitive than consensus primers, that also amplify IgH rearrangements from normal B cells that phisms cannot be excluded. A similar range of mutations has been observed in diffuse large cell lymphoma, 33 endemic compete for PCR primers and nucleotides. Detection sensitivity is further increased by blotting of the PCR product folBurkitt's lymphomas, 63 and multiple myeloma.
64
In comparison to NDN regions from the rearranged IgH lowed by hybridization with a radioactive probe that consists of the CDR3 domain flanked by short stretches of FR3 and JH genes from normal adult peripheral blood B lymphocytes 68 and B-ALL, 69 -72 the B-NHL NDN regions reported in this sequence. 42 Dilution of lymphoma DNA in peripheral blood DNA showed that the sensitivity of the method is approxipaper differ in two aspects. First, in B-NHL deletion of nucleotides from the 3Ј end of the VH gene appears to be limited, mately 10 −4 . Between different experiments the sensitivity was found to vary from 10 −3 to 10 −5 ; this may relate to difficulties as in seven rearranged IgH genes no deletions were observed and in the remaining four genes, 3 bp at most were deleted.
in mixing of genomic DNA samples. Three patients with different clinical courses were selected Based on published amino acid sequences, VH deletions also appear to be limited in diffuse large cell lymphoma, 33 monofor minimal disease study. The first patient (222) never achieved CCR, and the detection of the lymphoma-specific clonal gammopathy of undetermined significance, 73 and multiple myeloma. 64, 73 Second, the B-NHL NDN regions are rearranged IgH gene in blood and bone marrow samples from this patient is therefore not surprising. In the other two shorter than those published for normal B cells, 68 B-ALL, [69] [70] [71] [72] multiple myeloma, and monoclonal gammopathy. 73 Since patients, PCR positivity was detected during first CCR in blood and bone marrow samples in which no lymphoma cells were only in two lymphomas D elements could be clearly identified, it appears that only small D fragments were introduced detected by morphological examination and immunological marker analysis. In both patients, first CCR was followed by or that VH-JH joinings have occurred. 68 The cause and possible significance of the relative shortness of NDN regions in local relapse. Following treatment both patients achieved prolonged CCR, accompanied by PCR negativity of peripheral B-NHL remains to be determined. grade B cell NHL.
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